COVID19 coinfection exacerbates lung inflammation in TB patients.

G. Shepelkova (Moscow, Russian Federation), V. Evstifeev (Moscow, Russian Federation), R. Tarasov (Moscow, Russian Federation), V. Aliev (Moscow, Russian Federation), M. Bagirov (Moscow, Russian Federation), Y. Berezovskiy (Moscow, Russian Federation), M. Isaeva (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation)

Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Session: Tuberculosis, COVID-19 and other comorbidities
Session type: E-poster
Number: 1027

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Shepelkova (Moscow, Russian Federation), V. Evstifeev (Moscow, Russian Federation), R. Tarasov (Moscow, Russian Federation), V. Aliev (Moscow, Russian Federation), M. Bagirov (Moscow, Russian Federation), Y. Berezovskiy (Moscow, Russian Federation), M. Isaeva (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation). COVID19 coinfection exacerbates lung inflammation in TB patients.. 1027

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019


Why does chronic bronchitis and lung infection accelerate lung function decline
Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today
Year: 2021


Prevention of drug-induced liver injury in patients with pulmonary tuberculosis and chronic hepatitis C
Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Year: 2019

Exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 29: 1224-1238
Year: 2007



Impact of chronic bronchial infection on the lungs and beyond
Source: Eur Respir Monogr 2013; 60: 46-57
Year: 2013


A level of an alpha-1-proteinihibitor in patients with chronic bronchitis and lung tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 339s
Year: 2003

Detection of IFN-γ responses for diagnosis of tuberculosis infection in chronic inflammatory disease patients
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011


Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization
Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology
Year: 2006


Clinical-evolutive aspects of pulmonary tuberculosis at patients with chronic hepatitis
Source: Annual Congress 2007 - Tuberculosis
Year: 2007


Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012


Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004


The psychological type of chronic pulmonary TB patients
Source: Eur Respir J 2001; 18: Suppl. 33, 474s
Year: 2001

Management of tuberculosis in patients with chronic liver dysfunction
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007


Regulation of PMN apoptosis in the airways during community acquired pneumonia in COPD patients and controls
Source: Annual Congress 2006 - Molecular airway biology
Year: 2006


Azithromycin in the treatment of children with chronic inflammatory lung disease (CILD)
Source: Eur Respir J 2004; 24: Suppl. 48, 391s
Year: 2004

Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009

Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006


Prevalence and low diagnostics of chronic non-specific pulmonary diseases among pulmonary TB patients
Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector
Year: 2007


The pathogenesis of acute infection in COPD
Source: Breathe 2009; 5: 311-315
Year: 2009

The pathogenesis of acute infection in COPD
Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis
Year: 2008